新生儿缺氧缺血性脑病(HIE)是新生儿常见病、并可产生不良后果,为减轻后遗症,应用脑代谢激活剂,脑活素治疗HIE,许多临床报道都得到了满意的效果,但在急性期还是恢复期(起病后2~3周)使用问题上有较大争议,我科从1998年至2000年2月选择 HIE(轻度、中度)共30例,其中15例在急性期使用脑活素,15例在恢复期使用脑活素,发现在急 Neonatal hypoxic-ischemic encephalopathy (HIE) is a common disease in newborns, and can produce adverse consequences, in order to reduce the sequelae, the application of brain metabolic activators, cerebral HIE treatment of HIE, many clinical reports have been satisfactory results, but In the acute phase or recovery (onset 2 to 3 weeks) on the use of a more controversial issue, our department from 1998 to February 2000 selected HIE (mild, moderate) a total of 30 cases, of which 15 cases in the Acute use of cerebrolysin, 15 cases in the recovery of the use of cerebrolysin, found in urgent